BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Indraprastha Medical Corporation Ltd Industry :  Healthcare
BSE Code
532150
ISIN Demat
INE681B01017
Book Value (Rs)
80.7623837
NSE Symbol
INDRAMEDCO
Divident Yield %
1.1
Market Cap
(Rs In Cr.)
3,323
P/E (TTM)
18.1
EPS (TTM)
20.03
Face Value
(Rs)
10
Back
Indraprastha Medical Corporation standalone net profit rises 1.68% in the March 2026 quarter
13-May-26   Hrs IST

Net profit of Indraprastha Medical Corporation rose 1.68% to Rs 41.70 crore in the quarter ended March 2026 as against Rs 41.01 crore during the previous quarter ended March 2025. Sales rose 9.31% to Rs 364.81 crore in the quarter ended March 2026 as against Rs 333.75 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.06% to Rs 183.62 crore in the year ended March 2026 as against Rs 160.99 crore during the previous year ended March 2025. Sales rose 9.30% to Rs 1482.51 crore in the year ended March 2026 as against Rs 1356.36 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales364.81333.75 9 1482.511356.36 9
OPM %16.5918.37 -18.0018.01 -
PBDT66.3566.18 0 289.65260.65 11
PBT55.0155.27 0 246.02216.32 14
NP41.7041.01 2 183.62160.99 14

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)